Inebilizumab (Anti-CD19)

Ask the supplier | View on supplier's website

Inebilizumab (Anti-CD19) is an monoclonal antibody targeting CD19 antigen present on B cells. Inebilizumab can be used for multiple sclerosis and neuromyelitis optica research. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2564
Sku #	A2564-1mg*5
Pricing	1mg*5, $790.00

Feedback